MPM Asset Management »

Adaptimmune Therapeutics shares owned by MPM Asset Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by MPM Asset Management from 13F filings

Historical chart of MPM Asset Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by MPM Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by MPM Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.9M 6.3M 0.78
2023-06-30 $5.8M 6.3M 0.93